Literature DB >> 15538734

Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.

Iakov Shimanovich1, Sidonia Mihai, Gertie J Oostingh, T Toney Ilenchuk, Eva-B Bröcker, Ghislain Opdenakker, Detlef Zillikens, Cassian Sitaru.   

Abstract

Epidermolysis bullosa acquisita (EBA) and bullous pemphigoid (BP) are two clinically and immunologically distinct autoimmune subepidermal blistering skin diseases associated with IgG autoantibodies against the dermal-epidermal junction. BP antibodies are directed against the hemidesmosomal antigens BP180 and BP230, and those in patients with EBA target type VII collagen, a major component of anchoring fibrils. While the pathogenetic mechanisms of subepidermal blistering in BP have been previously studied using a passive transfer mouse model, the effector pathways of blister formation in EBA are largely unknown. Autoantibodies to type VII collagen and BP180 have recently been shown to induce leucocyte-mediated subepidermal cleavage in cryosections of human skin. The aim of the present study was to identify human leucocyte protease(s) instrumental in dermal-epidermal separation induced by autoantibodies to type VII collagen and BP180. When incubated with cryosections of human skin pretreated with IgG from patients with EBA or BP but not from patients with anti-laminin 5 mucous membrane pemphigoid or healthy controls, granulocytes were recruited to the dermal-epidermal junction and induced subepidermal splits. A combination of broad-range protease inhibitors as well as inhibitors of serine and matrix metalloproteases completely abolished dermal-epidermal separation induced by EBA or BP autoantibodies. When characterizing the proteases involved more specifically, selective inhibition of human leucocyte elastase or gelatinase B/MMP-9 was also found to result in suppression of blistering. These findings strongly suggest that elastase and gelatinase B are essential for granulocyte-mediated proteolysis resulting in dermal-epidermal separation in EBA and BP patients' skin. Copyright (c) 2004 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538734     DOI: 10.1002/path.1674

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  43 in total

Review 1.  What's new in blistering disorders?

Authors:  Paru Chaudhari; M Peter Marinkovich
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

Review 2.  Ocular mucous membrane pemphigoid: a review.

Authors:  Samanta Taurone; Marialuisa Spoletini; Massimo Ralli; Pietro Gobbi; Marco Artico; Laszlò Imre; Cecília Czakò; Illés Kovàcs; Antonio Greco; Alessandra Micera
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

3.  Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid.

Authors:  Kelly N Messingham; Jeffrey W Wang; Heather M Holahan; Rupasree Srikantha; Samantha C Aust; Janet A Fairley
Journal:  Exp Dermatol       Date:  2015-11-23       Impact factor: 3.960

4.  Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases.

Authors:  A V Marzano; A Tedeschi; E Berti; D Fanoni; C Crosti; M Cugno
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

Review 5.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

6.  Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters.

Authors:  Artem Vorobyev; Hideyuki Ujiie; Andreas Recke; Jacqueline J A Buijsrogge; Marcel F Jonkman; Hendri H Pas; Hiroaki Iwata; Takashi Hashimoto; Soo-Chan Kim; Jong Hoon Kim; Richard Groves; Unni Samavedam; Yask Gupta; Enno Schmidt; Detlef Zillikens; Hiroshi Shimizu; Ralf J Ludwig
Journal:  J Invest Dermatol       Date:  2015-02-17       Impact factor: 8.551

7.  Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII.

Authors:  Kinga Csorba; Alina Sesarman; Eva Oswald; Vasile Feldrihan; Anja Fritsch; Takashi Hashimoto; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-01-20       Impact factor: 9.261

Review 8.  Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.

Authors:  Michael P Shakarjian; Diane E Heck; Joshua P Gray; Patrick J Sinko; Marion K Gordon; Robert P Casillas; Ned D Heindel; Donald R Gerecke; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2009-10-15       Impact factor: 4.849

9.  Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells.

Authors:  Gabriel M Gordon; Dolena R Ledee; William J Feuer; M Elizabeth Fini
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

10.  Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

Authors:  Zhi Liu; Wen Sui; Minglang Zhao; Zhuowei Li; Ning Li; Randy Thresher; George J Giudice; Janet A Fairley; Cassian Sitaru; Detlef Zillikens; Gang Ning; M Peter Marinkovich; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-14       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.